Anavex Life Sciences Corp (AVXL)

[nidan7500]

BAM>>>BAM>>>BAM....NICE....just as hoped, a model trial for Precision Medicine....My guess is AAIC will want to know ALL about this....

The ANAVEX(R)2-73 Phase 2b/3 study design includes genomic precision medicine biomarkers identified in the ANAVEX(R)2-73 Phase 2a study. Primary and secondary endpoints will assess safety and both cognitive and functional efficacy, measured through ADAS-Cog, ADCS-ADL and CDR-SB. ANAVEX(R)2-73 Phase 2a Alzheimer's disease study previously demonstrated dose dependent improvement in exploratory endpoints of cognition (MMSE) and function (ADCS-ADL).

As they say in Australia...this takes stones, a MICRO BIO will lead the way after decades of BP consecutive failures and all they can do is WATCH AND LEARN...